- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02570243
High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion Forearm Artery Occlusion
This is a prospective, multi-center, superiority study of parallel design. Patients are enrolled if they are older than 18 years old, are scheduled for 5 or 6 Fr diagnostic coronary angiography and the interventional cardiologist is willing to proceed with radial access. Patients are randomized before diagnostic catheterization to receive intravenously either 100IU/Kg or 50 IU/Kg of unfractionated heparin (UFH) in a 1:1 ratio. Patients are discharged usually within 4 to 6 hours after coronary angiography.
Radial artery in each patient is evaluated either in-hospital or during a subsequent visit by one physician who is blinded to the actual antithrombotic treatment given. Radial artery is considered occluded if it exhibits ultrasonographically no antegrade flow signal both at baseline and after reevaluation on a second occasion, within 30 days after the index procedure. Initially patent arteries will not be reexamined and are thought to remain permanently patent. The investigators also monitor major bleeding (defined as ≥ 5g/dL decrease in hemoglobin or ≥15% decrease in hematocrit or any life-threatening bleeding (confirmed by MRI or computed tomography) and large local hematomas of the forearm (defined as those extending beyond the forearm).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Rion
-
Patras, Rion, Greece, 26500
- Patras University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Older than 18 years old
- Scheduled for 5 or 6 Fr diagnostic coronary angiography
- The interventional cardiologist is willing to proceed with radial access
- Written informed consent
Exclusion Criteria:
Before randomization
- chronic hemodialysis
- oral anticoagulation
- hemodynamic instability
- severe dermo-myoskeletal forearm deformities
- history of CABG and bilateral use of either the internal mammary or radial artery
- history of CABG and ipsilateral use of both the internal mammary and radial artery
- admission for elective PCI After randomization
- crossover to another arterial access site is required
- ad hoc PCI
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard dose of Heparin
50IU/Kg heparin intravenously
|
Unfractionated heparin 50IU/Kg
|
|
Experimental: High dose of Heparin
100IU/Kg heparin intravenously
|
Unfractionated Heparin 100IU/Kg
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radial artery occlusion
Time Frame: 30 days
|
Radial artery occlusion as assessed by Doppler Ultrasound
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Large local hematomas of the forearm
Time Frame: 30 days
|
large local hematomas of the forearm (defined as those extending beyond the forearm)
|
30 days
|
|
Major bleeding
Time Frame: 30 days
|
≥ 5g/dL decrease in hemoglobin or ≥15% decrease in hematocrit or any life-threatening bleeding (confirmed by MRI or computed tomography)
|
30 days
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PATRASCARDIOLOGY 20
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Angiography
-
Baylor Research InstituteCompletedCoronary Angioplasty | Coronary AngiographyUnited States
-
Hillel Yaffe Medical CenterUnknown
-
Ospedale Sandro Pertini, RomaCompletedPercutaneous Coronary Intervention | Coronary AngiographyItaly
-
Fundación Pública Andaluza Progreso y SaludHospital Universitario Reina Sofia de CordobaCompletedCoronary AngiographySpain
-
Meir Medical CenterCompletedCoronary AngiographyIsrael
-
Yuksek Ihtisas UniversityNot yet recruitingCoronary Angiography (CAG)Turkey
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompletedCoronary AngiographyFrance
-
University of FloridaCompletedCoronary AngiographyUnited States
Clinical Trials on Standard dose of Unfractionated heparin
-
University of California, Los AngelesCompletedPregnancy Related | Antepartum DVTUnited States
-
Allied Hospital FaisalabadNot yet recruiting
-
Robert F. JamesIndiana University School of MedicineSuspendedNeurobehavioral Manifestations | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, Intracranial | Intracranial Aneurysm | Heparin-induced Thrombocytopenia Type IIUnited States
-
Rajaie Cardiovascular Medical and Research CenterBrigham and Women's Hospital; Tehran Heart Center; Imam Khomeini Hospital; Masih... and other collaboratorsCompletedCovid19Iran, Islamic Republic of
-
Vanderbilt UniversityTerminatedHeart Failure | Acute Kidney Injury | Acute Renal FailureUnited States
-
Chen JingHanyang University; Renmin Hospital of Wuhan University; The Second Affiliated... and other collaboratorsRecruitingST-elevation Myocardial Infarction (STEMI) | Primary PCIChina
-
Beijing Chao Yang HospitalCompletedVascular Diseases | Thrombosis | Thromboembolism | Pulmonary EmbolismChina
-
University Medical Centre LjubljanaNot yet recruitingRenal Failure | End-Stage Kidney Disease | Hemodiafiltration | Chronic HemodialysisSlovenia
-
Nazareth HospitalUnknownObesity | Atrial Fibrillation | Chest Pain | Venous Thromboembolism | Morbid Obesity | AnginaUnited States
-
University Hospital, GrenobleNot yet recruitingVenous Thromboembolism | Severe Trauma PatientFrance